4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-064127
President and CEO gave up 871 shares (to pay taxes)
- President and CEO acquired 3,034 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal President and CEO | 2020-12-15 | Option exercise | +3,034 | 1,149,185 | D: show line 1 in the form | ||
| Walker Neal President and CEO | 2020-12-15 | Shares withheld for taxes | −871 | $4.59 | $3,998 | 1,148,314 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Walker Neal President and CEO | 2020-12-15 | Option exercise · Restricted Stock Units | −3,034 | 0 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…